In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes.
Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, McDonald RA, Falkowski NR, Metcalf JD, Kaye KS, Woods RJ, Prescott HC, Sjoding MW, Dickson RP.
Chanderraj R, et al. Among authors: dickson rp.
Eur Respir J. 2023 Feb 9;61(2):2200910. doi: 10.1183/13993003.00910-2022. Print 2023 Feb.
Eur Respir J. 2023.
PMID: 36229047
Free PMC article.